The aim of this prospective, observational, non-interventional, multi-centre study of the diagnostic use of DISQVER in neutropenic patients with FN is to provide further evidence of the efficacy of an NGS-based approach for detecting bloodstream infection in neutropenic patients.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Age ≥18 years
* Informed consent
* Neutropenia defined as \<500 ANC (Absolute neutrophil Count)/µl or \<1000 WBC (White bloddcell Count)/µl if ANC is not available
* Fever (with an onset \< 24h) or Sepsis (with an onset \<24h) Patients with a life-threatening - organ dysfunction caused by a dysregulated host response to a suspected or proven infection.
Exclusion Criteria:
* Age \< 18 years
* Refusal or inability to give consent Inability to give informed consent if no acceptable patient representative is available
* Patients who had previously been included, but develop a new episode of fever during the same hospitalization, will not be included a second time
* Death is deemed imminent and inevitable
Primary outcome measure(s)
Evaluation of the performance of a NGS-based — Baseline Number of Participants with detection of pathogen
Trial sites (6)
Facility
City
Region
Status
University Hospital of Cologne
Cologne
Germany
Recruiting
Hospital Dessau
Dessau
Germany
Recruiting
University Hospital of Essen
Essen
Germany
Recruiting
University Hospital of Frankfurt
Frankfurt am Main
Germany
Recruiting
University Hospital of Leipzig
Leipzig
Germany
Recruiting
University Hospital of Magdeburg
Magdeburg
Germany
Recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.